BD ChloraPrep Clear, 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) Ste...

FDA Drug Recall #D-1168-2023 - Class II, August 25, 2023

Recall Summary

Recall Number D-1168-2023
Classification Class II - Moderate risk
Date Initiated August 25, 2023
Status Completed
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm CareFusion 213, LLC
Location El Paso, TX
Product Type Drugs
Quantity 398,160 cartons

Product Description

BD ChloraPrep Clear, 2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA) Sterile Solution, 0.03mL (1 ml) each, 60 applicators in carton, applicator is sterile if package is intact. CareFusion 213, LLC, El Paso, TX 79912, subsidiary of Becton, Dickinson and Co., NDC 54365-400-31 REF 930480 Product is packaged in the following manner: There is one (1) sterile applicator (sponge) per pouch. Each inner carton contains sixty (60) pouches. There are four (4) inner cartons per shipping case (total of 240 pouches per case).

Reason for Recall

Stability data does not support expiry: Shelf-life of the impacted lots of BD ChloraPrep" Clear 1 mL Applicator cannot be substantiated beyond 12-months although labeled with 36-month expiry. Stability studies indicate that the impacted lots, if stored at 30¿C/75% relative humidity continuously beyond 12 months, may exhibit growth of Aspergillus penicillioides.

Distribution Pattern

Distributed nationwide to 100 consignees. Please refer to consignee list.

Lot / Code Information

Lot # 2272350, Exp. Date 09/30/2025 and Lot # 2301939, Exp. Date 09/30/2025

Other Recalls from CareFusion 213, LLC

Recall # Classification Product Date
D-0690-2026 Class II BD ChloraPrep Clear, (2% w/v chlorhexidine gluc... Jul 9, 2026
D-0652-2026 Class II BD ChloraPrep CLear, (2% w/v chlorhexidine gluc... Jun 11, 2026
D-0650-2026 Class II BD ChloraPrep Scrub Teal, (2% w/v chlorhexidine... Jun 11, 2026
D-0643-2026 Class II BD ChloraPrep Hi-Lite Orange, (2% w/v chlorhexi... Jun 11, 2026
D-0646-2026 Class II ChloraPrep FREPP, Clear, (2% w/v chlorhexidine ... Jun 11, 2026

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications, even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications, use a drug take-back program.